Source: Frontiers in Pharmacology. Unidade: ESALQ
Subjects: ANTIOXIDANTES, CANDIDÍASE, CITOCINAS, DISGEUSIA, ESTUDOS RANDOMIZADOS, NEOPLASIAS DE CABEÇA E PESCOÇO, PRÓPOLIS, RADIOTERAPIA, TRANSTORNOS DE DEGLUTIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Patrícia Maria et al. Brazilian organic propolis for prevention and treatment of radiation-related oral acute toxicities in head and neck cancer patients: a double-blind randomized clinical trial. Frontiers in Pharmacology, v. 13, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.973255. Acesso em: 18 ago. 2024.APA
Fernandes, P. M., Rosalen, P. L., Fernandes, D. T., Dias-Neto, E., Alencar, S. M., Bueno-Silva, B., et al. (2022). Brazilian organic propolis for prevention and treatment of radiation-related oral acute toxicities in head and neck cancer patients: a double-blind randomized clinical trial. Frontiers in Pharmacology, 13, 1-13. doi:10.3389/fphar.2022.973255NLM
Fernandes PM, Rosalen PL, Fernandes DT, Dias-Neto E, Alencar SM, Bueno-Silva B, Alves F de A, Lopes MA. Brazilian organic propolis for prevention and treatment of radiation-related oral acute toxicities in head and neck cancer patients: a double-blind randomized clinical trial [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-13.[citado 2024 ago. 18 ] Available from: https://doi.org/10.3389/fphar.2022.973255Vancouver
Fernandes PM, Rosalen PL, Fernandes DT, Dias-Neto E, Alencar SM, Bueno-Silva B, Alves F de A, Lopes MA. Brazilian organic propolis for prevention and treatment of radiation-related oral acute toxicities in head and neck cancer patients: a double-blind randomized clinical trial [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-13.[citado 2024 ago. 18 ] Available from: https://doi.org/10.3389/fphar.2022.973255